Xanthus Pharmaceuticals
Cambridge
About Xanthus Pharmaceuticals
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $76.2M
- Funding stage: M&A
- Last round: Series B (Dec 2006)
- Website: xanthus.com
- Phone: (617)225-0522
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/xanthus-pharmaceuticals-2902259 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.